Less than 1 min.Read

Nanoveu: Accelerates international distribution agreements

March 10, 2021

Enquiries into Nanoveu’s (NVU) suite of antiviral protection technologies are continuing to develop momentum
Nanoveu’s flagship antiviral tech, Nanoshield, has demonstrated to be highly effective at eradicating viruses
Nanoveu has signed an exclusive distribution agreement has signed with Vital Medikal for distribution in the Republic of Turkey
The agreement between the parties is effective immediately over a 12-month term, with the ability to extend the agreement should all sales targets met
Nanoveu has also signed a non-exclusive distribution agreement for Hong Kong with Asia Pro Lab for a 12-month term
Nanoveu shares are up 14 per cent, trading at 5.7 cents